Plaque Psoriasis Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Plaque Psoriasis Treatment Market By Product Type (Interleukin Inhibitors, Tumour Necrosis Factor (TNF), and Others), By Route of Administration (Topical, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Plaque Psoriasis Treatment Market size is valued at USD 15,468.07 million in 2021 and is expected to reach USD 26,338.21 million by 2028, at a CAGR of 7.9% during the forecast period 2022-2028. Plaque psoriasis is the most common kind of psoriasis, accounting for 80% to 90% of total psoriasis occurrences. Psoriasis plaques are large, red areas on the skin caused by an autoimmune disease. These plaques are most typically found on the knees, scalp, and elbows, although they can also be found on other parts of the body. Itchy, uncomfortable, and prone to bleeding. Plaque psoriasis has an aetiology that is unknown. Infections, severe sunburns, stress, smoking, alcohol consumption, obesity, dry skin, and certain drugs are all known psoriasis triggers. Itching, discomfort, stinging, and skin tightness are all prominent symptoms of plaque psoriasis. A thorough skin examination is usually used to diagnose plaque psoriasis. A biopsy may be required to confirm the diagnosis in some cases. Psoriasis is becoming more common across the country. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Plaque Psoriasis Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Plaque Psoriasis Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Plaque Psoriasis Treatment Market

MARKET SUMMARY
-
7.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.9%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Plaque Psoriasis Treatment Market

  • The global Plaque Psoriasis Treatment Market report gives comprehensive outlook on Plaque Psoriasis Treatment Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Plaque Psoriasis Treatment Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Novartis AG (Switzerland)
  • AbbVie Inc.(U.S)
  • Amgen, Inc. (U.S)
  • Johnson & Johnson (U.S)
  • Eli Lilly and Company (U.S)
Plaque Psoriasis Treatment Market

DRIVERS AND RESTRAINTS

One of the primary factors driving the growth of the psoriasis treatment market is the rising prevalence of psoriasis around the world. The market is growing due to a rise in manufacturer cooperation and increased awareness of treatment options. The market is further influenced by the rise in disease burden and demand for psoriasis treatments in emerging nations, as well as a surge in government efforts. Furthermore, technological advancements, population growth, increased research and development for treatment improvement, and an increase in healthcare expenditure all benefit the psoriasis treatment industry.


North-America got significant share

Plaque Psoriasis Treatment Market

North America accounted for larger revenue share in global plaque psoriasis treatment market with moderate CAGR. In 2018, North America market estimated to account for larger revenue share in global market with the market revenue share of 65.1% in the global market and projected to grow at 7.9% CAGR over 2018 and 2023. The North America market projected to reach US$ 12,294.0 Mn by 2026.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Global plaque psoriasis treatment market expanding at 7.9% CAGR over 2022 to 2028 to reach a market value of US$ 20,388.2 Mn by 2028 owing to increase in the prevalence of the psoriasis conditions
  • Based on product type Interleukin Inhibitors expected to account a significant revenue share in global plaque psoriasis treatment market with a share of XX% (2022) in the global market and projected to grow at 7.9% CAGR over 2022 and 2028. Interleukin Inhibitors projected to reach US$ XX Mn by 2028
  • Tumor Necrosis Factor (TNF) expected to account for low revenue share in global plaque psoriasis treatment market with a share of 29.2% (2022) in the global market and projected to de-grow at -3.8% CAGR over 2016 and 2021. The segment projected to reach US$ XX Mn by 2028
  • Players are focusing on introducing novel biologic therapies to retain the market position in global plaque psoriasis market

Key

Features of the Report

Plaque Psoriasis Treatment Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Plaque Psoriasis Treatment Market

  1. Executive Summary
  2. Global Plaque Psoriasis Treatment Market Introduction

2.1. Global Plaque Psoriasis  Treatment Market – Taxonomy

  1. Global Plaque Psoriasis Treatment Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Plaque Psoriasis  Treatment Market Dynamic Factors – Impact Analysis

3.6. Commercial Investments of Major Brands

3.7. Drug Development Programs of Major Brands

  1. Global Plaque Psoriasis Treatment Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023

4.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market, By Product Type, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1. Interleukin Inhibitors

5.1.1. Tildrakizumab

5.1.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Guselkumab

5.1.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3. Market Opportunity Analysis

5.1.3. Ixekizumab

5.1.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3.3. Market Opportunity Analysis

5.1.4. Secukinumab

5.1.4.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.4.3. Market Opportunity Analysis

5.1.5. Ustekinumab

5.1.5.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.5.3. Market Opportunity Analysis

5.1.6. Brodalumab

5.1.6.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.6.3. Market Opportunity Analysis

5.2. Tumor Necrosis Factor (TNF) Inhibitors

5.2.1. Etanercept

5.2.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.1.3. Market Opportunity Analysis

5.2.2. Adalimumab

5.2.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.2.3. Market Opportunity Analysis

5.2.3. Infliximab

5.2.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3.3. Market Opportunity Analysis

5.3. Others

5.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market Forecast, By Route of Administration, 2015 – 2017and Forecast, 2018 – 2023

6.1. Topical

6.1.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Parenteral

6.2.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Others

6.3.1. Market Analysis, 2015 – 2017 and Forecast, 2018 – 2023 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market Forecast, By Distribution Channel, 2015 – 2017and Forecast, 2018 – 2023

7.1. Hospital  Pharmacies

7.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Retail Pharmacies

7.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

  1. Global Plaque Psoriasis Treatment Market Forecast, By Region, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.1. North America

8.1.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. RoW

8.3.1. Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Global Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Region, 2018 – 2023

  1. North America Plaque Psoriasis Treatment Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

9.1. Product Type Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Interleukin Inhibitors

9.1.1.1. Tildrakizumab

9.1.1.2. Guselkumab

9.1.1.3. Ixekizumab

9.1.1.4. Secukinumab

9.1.1.5. Ustekinumab

9.1.1.6. Brodalumab

9.1.2. Tumor Necrosis Factor (TNF) Inhibitors

9.1.2.1. Etanercept

9.1.2.2. Adalimumab

9.1.2.3. Infliximab

9.1.3. Others

9.2. Route of Administration Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Topical

9.2.2. Parenteral

9.2.3. Others

9.3. Distribution Channel Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Others

9.4. Country Analysis 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023

  1. Europe Plaque Psoriasis Treatment Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

10.1. Product Type Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Interleukin Inhibitors

10.1.1.1. Tildrakizumab

10.1.1.2. Guselkumab

10.1.1.3. Ixekizumab

10.1.1.4. Secukinumab

10.1.1.5. Ustekinumab

10.1.1.6. Brodalumab

10.1.2. Tumor Necrosis Factor (TNF) Inhibitors

10.1.2.1. Etanercept

10.1.2.2. Adalimumab

10.1.2.3. Infliximab

10.1.3. Others

10.2. Route of Administration Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Topical

10.2.2. Parenteral

10.2.3. Others

10.3. Distribution Channel Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Others

10.4. Country Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Germany

10.4.2. UK

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023

  1. RoW Plaque Psoriasis Treatment Market Analysis, 2015 – 2017and Forecast, 2018 – 2023 (Revenue, USD Mn)

11.1. Product Type Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Interleukin Inhibitors

11.1.1.1. Tildrakizumab

11.1.1.2. Guselkumab

11.1.1.3. Ixekizumab

11.1.1.4. Secukinumab

11.1.1.5. Ustekinumab

11.1.2. Tumor Necrosis Factor (TNF) Inhibitors

11.1.2.1. Adalimumab

11.1.2.2. Infliximab

11.1.3. Others

11.2. Route of Administration Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Topical

11.2.2. Parenteral

11.2.3. Others

11.3. Distribution Channel Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Others

11.4. Country Analysis 2015 – 2017and Forecast 2018 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. Brazil

11.4.5. Others

11.5. Asia-Pacific Plaque Psoriasis  Treatment Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Distribution Channel and Country, 2018 – 2023

  1. Competition Landscape

12.1. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

12.1.1. Novartis AG

12.1.2. AbbVie Inc.

12.1.3. Amgen, Inc

12.1.4. Johnson & Johnson

12.1.5. Eli Lilly and Company

12.1.6. Celgene Corporation

12.1.7. Sun Pharmaceuticals Industries Ltd.

  1. Research Methodology
  2. Key Assumptions and Acronyms

Figure 01: Global Plaque Psoriasis Treatment Market Revenue Share (%), by Product Type (2017)

Figure 02: Global Plaque Psoriasis Treatment Market Revenue Share (%), by Route of Administration (2017)

Figure 03: Global Plaque Psoriasis Treatment Market Revenue (US$ Mn), by Distribution Channel (2015, 2017, and 2023)

Figure 04: Global Plaque Psoriasis Treatment Market Revenue Share (%) by Region (2017)

Figure 05: Global Plaque Psoriasis Treatment Market – Regional Revenue Hotspots (2017)

Figure 06: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2015-2023

Figure 07: Global Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2015, 2017, & 2023

Figure 08: Global Plaque Psoriasis Treatment Market Share (%), By Product Type 2018 & 2023

Figure 09: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Product Type, 2018 – 2023

Figure 10: Global  Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Interleukin Inhibitors 2015-2023

Figure 11: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Tumor Necrosis Factor (TNF) 2015-2023

Figure 12: Global  Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Others 2015-2023

Figure 13: Global Plaque Psoriasis Treatment Market Share (%), By Route of Administration 2018 & 2023

Figure 14: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Route of Administration , 2018 – 2023

Figure 15: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Topical administration, 2012-2023

Figure 16: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Parenteral administration, 2012-2023

Figure 17: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), Analysis, By Others, 2012-2023

Figure 18: Global Plaque Psoriasis Treatment Market Share (%), By Distribution Channel, 2018 & 2023

Figure 19: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), By Distribution Channel, 2018 – 2023

Figure 20: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Hospital Pharmacies, 2012-2023

Figure 21: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), By Retail Pharmacies, 2012-2023

Figure 22: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn, By Others, 2012-2023

Figure 23: Global Plaque Psoriasis Treatment Market Share (%), By Region, 2018 & 2023

Figure 24: Global Plaque Psoriasis Treatment Market Y-o-Y Growth (%), by Region, 2018 – 2023

Figure 25: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023

Figure 26: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023

Figure 27: Rest of the world Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2012-2023

Figure 28: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 29: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 30: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 31: Global Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Figure 32: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023

Figure 33: North America Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023

Figure 34: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017

Figure 35: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017

Figure 36: North America Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017

Figure 37: North America Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017

Figure 38: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 39: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 40: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 41: North America Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Figure 42: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023

Figure 43: Europe Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023

Figure 44: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017

Figure 45: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017

Figure 46: Europe Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017

Figure 47: Europe Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017

Figure 48: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 49: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 50: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 51: Europe Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Figure 52: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn) and Y-o-Y Growth (%), 2012-2023

Figure 53: RoW Plaque Psoriasis Treatment Market – Market Opportunity (US$ Mn), 2012, 2017, & 2023

Figure 54: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Product Type, 2017

Figure 55: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Route of Administration, 2017

Figure 56: RoW Plaque Psoriasis Treatment Market Share Analysis(%), by Distribution Channel, 2017

Figure 57: RoW Plaque Psoriasis Treatment Market Share Analysis (%), by Country, 2017

Figure 58: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Product Type 2018 – 2023

Figure 59: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Route of Administration, 2018 – 2023

Figure 60: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Distribution Channel, 2018 – 2023

Figure 61: RoW Plaque Psoriasis Treatment Market – Opportunity Analysis, By Country, 2018 – 2023

Table 01: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 02: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 03: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023

Table 04: Global Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Region, 2012-2023

Table 05: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023

Table 06: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 07: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 08: North America Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023

Table 09: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023

Table 10: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 11: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 12: Europe Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023

Table 13: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Country, 2012-2023

Table 14: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Product Type, 2012-2023

Table 15: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Route of Administration, 2012-2023

Table 16: RoW Plaque Psoriasis Treatment Market – Historical, Forecast Market Sizes (US$ Mn), By Distribution Channel, 2012-2023


Report

Company Profile

  • Novartis AG (Switzerland)
  • AbbVie Inc.(U.S)
  • Amgen, Inc. (U.S)
  • Johnson & Johnson (U.S)
  • Eli Lilly and Company (U.S)
  • Celgene Corporation (U.S)
  • Sun Pharmaceuticals Industries Ltd. (India)

Description

Plaque Psoriasis Treatment Market size is valued at USD 15,468.07 million in 2021 and is expected to reach USD 26,338.21 million by 2028, at a CAGR of 7.9% during the forecast period 2022-2028. Plaque psoriasis is the most common kind of psoriasis, accounting for 80% to 90% of total psoriasis occurrences. Psoriasis plaques are large, red areas on the skin caused by an autoimmune disease. These plaques are most typically found on the knees, scalp, and elbows, although they can also be found on other parts of the body. Itchy, uncomfortable, and prone to bleeding. Plaque psoriasis has an aetiology that is unknown. Infections, severe sunburns, stress, smoking, alcohol consumption, obesity, dry skin, and certain drugs are all known psoriasis triggers. Itching, discomfort, stinging, and skin tightness are all prominent symptoms of plaque psoriasis. A thorough skin examination is usually used to diagnose plaque psoriasis. A biopsy may be required to confirm the diagnosis in some cases. Psoriasis is becoming more common across the country. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Plaque Psoriasis Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Plaque Psoriasis Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX